The chemokines, XCL1, XCL2, CCL4, CCL5, CXCL13, CXCL11, CXCL10 and CXCL9 were found to be upregulated in the high-immunity cohort, which recruit different subsets of immune cells into the tumor microenvironment. This evidence concerns the gene CCL5 and neoplasm.